fbpx

Clinical expertise

Dr Michal Ajzensztejn specialises in diabetes, growth concerns, puberty issues and genetic conditions with an endocrine component.

She regularly treats patients with conditions such as:

  • diabetes (type 1, 2, neonatal diabetes, maturity onset diabetes of the young (MODY))
  • growth concerns (short stature and tall stature)
  • thyroid hormone conditions
  • puberty issues (delayed growth)
  • adrenal gland issues
  • pituitary hormones issues
  • genetic endocrine disorders
  • paediatric endocrinology and gynaecology conditions such as ovarian insufficiency
  • differences in sex development (DSD)
  • neuroendocrine conditions
  • obesity
  • turner’s syndrome

She performs treatments such as:

  • diagnostics and investigations
  • dynamic endocrine tests
  • insulin pumps (including automated insulin delivery systems)
  • continuous glucose monitoring
  • flash glucose monitors


Biography

Dr Michal Ajzensztejn is a consultant in paediatric diabetes and endocrinology.

She joined Evelina London Children’s Hospital in 2013 having previously worked as a consultant in paediatric endocrinology and diabetes at The Royal Belfast Hospital for sick children. She is the clinical lead for paediatric diabetes and was clinical lead for both paediatric diabetes and endocrinology from 2015-2020.

Dr Ajzensztejn received her Bachelor of Medicine and a first class honours B.Sc. in Psychology (intercalated) from Southampton University Medical School in 2002. She went on to received the International Society for Paediatric and Adolescent Diabetes (ISPAD) Clinical Research Fellowship award in 2011.

She undertook her Endocrinology and Diabetes training in London at Great Ormond Street Hospital, University College Hospital London and Chelsea and Westminster. She spent a year overseas as a clinical fellow at the Schneider Children’s Medical Centre, working on the artificial pancreas project closing the loop between insulin pumps and continuous glucose monitors.

She received the Alex Russell Paediatric Endocrinology Prize from the Royal Society of Medicine in 2013.


Research interests

Dr Michal Ajzensztejn is a co-founder of the South East Coast Research Group for Diabetes and is the research and guidelines lead for the South East Coast Diabetes Network.

She is a paediatric representative on the Extraordinary London Type 1 Diabetes Network Steering Group part of NHS London Clinical Networks NHS England and NHS Improvements.